Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Rabanel

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 10, 2010
Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticlesSherief Essa, Jean Michel Rabanel, Patrice Hildgen
International Journal of Pharmaceutics|January 12, 2010
Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticlesSherief Essa, Jean Michel Rabanel, Patrice Hildgen
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2014
Assessment of PEG on polymeric particles surface, a key step in drug carrier translationJean-Michel Rabanel, Patrice Hildgen, Xavier Banquy
International Journal of Pharmaceutics|April 5, 2011
Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting densitySherief Essa, Jean Michel Rabanel, Patrice Hildgen
Advanced Drug Delivery Reviews|June 23, 2022
Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findingsPhilippe Delbreil, Jean-Michel Rabanel, Xavier Banquy, et al.
Trends in Pharmacological Sciences|December 17, 2019
Overcoming the Brain Barriers: From Immune Cells to NanoparticlesMarc Charabati, Jean-Michel Rabanel, Charles Ramassamy, et al.
Biotechnology Progress|June 25, 2009
Progress technology in microencapsulation methods for cell therapyJean-Michel Rabanel, Xavier Banquy, Hamza Zouaoui, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 4, 2020
Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challengeJean-Michel Rabanel, Philippe Delbreil, Xavier Banquy, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2020
Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailabilityJean-Michel Rabanel, Pierre-Alexandre Piec, Sarra Landri, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 23, 2009
Functionalized nanospheres loaded with anti-angiogenic drugs: cellular uptake and angiosuppressive efficacyTaha Hammady, Jean-Michel Rabanel, Renu Singh Dhanikula, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 10, 2010
Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticlesSherief Essa, Jean Michel Rabanel, Patrice Hildgen
International Journal of Pharmaceutics|January 12, 2010
Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticlesSherief Essa, Jean Michel Rabanel, Patrice Hildgen
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2014
Assessment of PEG on polymeric particles surface, a key step in drug carrier translationJean-Michel Rabanel, Patrice Hildgen, Xavier Banquy
International Journal of Pharmaceutics|April 5, 2011
Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting densitySherief Essa, Jean Michel Rabanel, Patrice Hildgen
Advanced Drug Delivery Reviews|June 23, 2022
Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findingsPhilippe Delbreil, Jean-Michel Rabanel, Xavier Banquy, et al.
Trends in Pharmacological Sciences|December 17, 2019
Overcoming the Brain Barriers: From Immune Cells to NanoparticlesMarc Charabati, Jean-Michel Rabanel, Charles Ramassamy, et al.
Biotechnology Progress|June 25, 2009
Progress technology in microencapsulation methods for cell therapyJean-Michel Rabanel, Xavier Banquy, Hamza Zouaoui, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 4, 2020
Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challengeJean-Michel Rabanel, Philippe Delbreil, Xavier Banquy, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2020
Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailabilityJean-Michel Rabanel, Pierre-Alexandre Piec, Sarra Landri, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 23, 2009
Functionalized nanospheres loaded with anti-angiogenic drugs: cellular uptake and angiosuppressive efficacyTaha Hammady, Jean-Michel Rabanel, Renu Singh Dhanikula, et al.
Pageof 3